Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.
Patel JL, Erickson JA, Roberts WL, Grenache DG
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to evaluate the stability of CYFRA 21-1 in serum specimens and compare the sensitivity of CYFRA 21-1, squamous cell carcinoma antigen (SCCa), and carcinoembryonic antigen (CEA) as markers for non-small cell lung cancer (NSCLC). After experimental storage specimens were stored for up to 1 week at 4-8 degrees C or for more than 1 week at -20 degrees C.
Summary of Findings
CYFRA 21-1 was stable in serum for more than 48 h in specimens stored at room temperature and more than 14 days in specimens stored at 4 degrees C regardless of concentration. Gender and age had no effects on CYFRA 21-1 levels. The sensitivity of CYFRA 21-1 increased with NSCLC tumor stage. A slight increase in sensitivity with tumor stage was also observed for CEA, but not SCCa. In stage II-IV NSCLC tumors, CYFRA 21-1 alone was more sensitive than SCCa and CEA combined. The use of either SCCa or CEA with CYFRA 21-1 increased the sensitivity. The combination of all three markers resulted in the highest sensitivity.
Biospecimens
FluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalNeoplasticCarcinomaPlatforms
ProteinClinical chemistry/auto analyzerProteinELISAPeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level 0.9 ng/mL CYFRA 21-118.2 ng/mL CYFRA 21-136.2 ng/mL CYFRA 21-154.1 ng/mL CYFRA 21-171.4 ng/mL CYFRA 21-1Preaquisition Patient age 19-60 yearsPreaquisition Patient gender FemaleMaleStorage Storage duration 0 h10 days14 days16 h2 days24 h4 days4 h48 h7 days8 hStorage Storage temperature 4 degrees CRoom temperatureClinical chemistry/auto analyzer Specific Targeted peptide/protein Carcinoembryonic antigen (CEA)Cytoleratin 19 fragment 21-1 (CYFRA 21-1)Squamous cell carcinoma antigen (SCCa)